<DOC>
	<DOCNO>NCT00634114</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy esomeprazole 20 mg daily 24 week maintenance Reflux Esophagitis patient heal reflux esophagitis comparison omeprazole 10 mg daily esomeprazole 10 mg daily assessment presence/absence recurrence Reflux Esophagitis throughout treatment period ( randomisation treatment completion ) accord Los Angeles classification .</brief_summary>
	<brief_title>Reflux Esophagitis Phase III Study ( Maintenance Treatment )</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Esophagitis , Peptic</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<criteria>Patients heal Reflux Esophagitis verify EGD precede study ( D961HC00002 ) Patients endoscopically verify heal Reflux Esophagitis EGD receive general treatment PPI Gastric duodenal ulcer verify EGD within 12 week randomisation . Use PPI 14 day EGD perform screen visit day randomisation .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Reflux Esophagitis</keyword>
</DOC>